azacitidine has been researched along with Diffuse Parenchymal Lung Disease in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ades, L; Bally, C; Bergeron, A; Burns, R; Fenaux, P; Hilmi, M; Lorillon, G | 1 |
Chinen, Y; Horiike, S; Kiyota, M; Kobayashi, T; Kuroda, J; Maegawa, S; Matsumoto, Y; Mizutani, S; Nagoshi, H; Shimura, Y; Taniwaki, M | 1 |
Kalra, A; Kurmayagari, K; Palaniswamy, C; Sekhri, A; Selvaraj, DR | 1 |
Jones, PA; Pillai, AR; Sadik, W; Thachil, J | 1 |
Hueser, CN; Patel, AJ | 1 |
5 other study(ies) available for azacitidine and Diffuse Parenchymal Lung Disease
Article | Year |
---|---|
Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Combined Modality Therapy; Drug Resistance; Humans; Hydroxyurea; Leukemia, Myelomonocytic, Chronic; Lung Diseases, Interstitial; Male; Middle Aged; Oxygen Inhalation Therapy; Prednisone; Tomography, X-Ray Computed | 2018 |
Azacitidine-associated acute interstitial pneumonitis.
Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Fatal Outcome; Humans; Lung; Lung Diseases, Interstitial; Male; Myelodysplastic Syndromes; Radiography | 2014 |
Interstitial lung disease associated with azacitidine use: a case report.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Myelodysplastic Syndromes; Steroids | 2012 |
Interstitial pneumonitis--An important differential diagnosis for pulmonary sepsis in haematology patients.
Topics: Aged; Antineoplastic Agents; Azacitidine; Diagnosis, Differential; Female; Hematology; Humans; Lung Diseases, Interstitial; Myelodysplastic Syndromes; Pneumonia; Sepsis | 2012 |
Azacitidine-associated hyperthermia and interstitial pneumonitis in a patient with myelodysplastic syndrome.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Female; Fever; Glucocorticoids; Humans; Lung Diseases, Interstitial; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Probability; Respiratory Distress Syndrome | 2007 |